Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement

被引:298
作者
机构
[1] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA
基金
美国医疗保健研究与质量局;
关键词
RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; QUALITY IMPROVEMENT; PHARMACOTHERAPY; PSYCHOTHERAPY; IMPACT;
D O I
10.7326/0003-4819-151-11-200912010-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for depression in adults. Methods: The USPSTF examined evidence on the benefits and harms of screening primary care patients for depression, including direct evidence that depression screening programs improve health outcomes. The USPSTF did not reexamine evidence for those key questions that had strong, consistent evidence in the 2002 review, including questions about the accuracy of screening instruments in identifying depressed adult patients in primary care settings, and the efficacy of treatment of depressed adults with antidepressants or psychotherapy. New areas of evidence considered for this review (and not reviewed in 2002) include efficacy of treatment of depression in older adult patients, harms of screening for depression in primary care settings, and adverse events from treatment of depression in adults. Recommendations: The USPSTF recommends screening adults for depression when staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment, and follow-up. (Grade B recommendation) The USPSTF recommends against routinely screening adults for depression when staff-assisted depression care supports are not in place. There may be considerations that support screening for depression in an individual patient. (Grade C recommendation)
引用
收藏
页码:784 / W256
页数:10
相关论文
共 23 条
[1]  
*AM COLL OBST GYN, 2007, GUID WOM HLTH CAR RE, P294
[2]  
[Anonymous], 2009, AHRQ PUBLICATION
[3]  
[Anonymous], 2001, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD000561
[4]  
[Anonymous], 2002, AHRQ PUBLICATION
[5]   Remission in major depressive disorder: A comparison of pharmacotherapy, psychotherapy, and control conditions [J].
Casacalenda, N ;
Perry, JC ;
Looper, K .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (08) :1354-1360
[6]   SSRIs and upper gastrointestinal bleeding - What is known and how should it influence prescribing? [J].
Dalton, SO ;
Sorensen, HT ;
Johansen, C .
CNS DRUGS, 2006, 20 (02) :143-151
[7]   Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials [J].
Fergusson, D ;
Doucette, S ;
Cranley, K ;
Glass, KC ;
Shapiro, S ;
Healy, D ;
Hebert, P ;
Hutton, B .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7488) :396-399
[8]  
*GLAXOSMITHKLINE, 2006, BRIEF DOC PAR AD SUI
[9]   Effectiveness of screening and treatment for depression in ambulatory indigent patients [J].
Jarjoura, D ;
Polen, A ;
Baum, E ;
Kropp, D ;
Hetrick, S ;
Rutecki, G .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (01) :78-84
[10]  
LEVENSON M, 2006, DEC 13 M PSYCH DRUGS, P14